Cambiar Investors LLC grew its position in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN) by 2.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,398,020 shares of the medical equipment provider’s stock after purchasing an additional 109,105 shares during the quarter. Smith & Nephew SNATS makes up about 3.1% of Cambiar Investors LLC’s portfolio, making the stock its 9th biggest holding. Cambiar Investors LLC owned 1.23% of Smith & Nephew SNATS worth $196,488,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the company. Bessemer Group Inc. increased its holdings in Smith & Nephew SNATS by 400.2% in the 3rd quarter. Bessemer Group Inc. now owns 2,781 shares of the medical equipment provider’s stock worth $102,000 after acquiring an additional 2,225 shares in the last quarter. Greenleaf Trust acquired a new stake in Smith & Nephew SNATS during the 2nd quarter worth $207,000. Paloma Partners Management Co acquired a new stake in Smith & Nephew SNATS during the 1st quarter worth $200,000. Quantbot Technologies LP boosted its stake in Smith & Nephew SNATS by 270.0% during the 2nd quarter. Quantbot Technologies LP now owns 7,277 shares of the medical equipment provider’s stock worth $253,000 after purchasing an additional 5,310 shares during the last quarter. Finally, The Manufacturers Life Insurance Company boosted its stake in Smith & Nephew SNATS by 0.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 7,437 shares of the medical equipment provider’s stock worth $260,000 after purchasing an additional 63 shares during the last quarter. 6.45% of the stock is owned by hedge funds and other institutional investors.

WARNING: “Smith & Nephew SNATS, Inc. (SNN) Stake Boosted by Cambiar Investors LLC” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/11/13/smith-nephew-snats-inc-snn-stake-boosted-by-cambiar-investors-llc.html.

SNN has been the topic of several recent research reports. Zacks Investment Research raised shares of Smith & Nephew SNATS from a “hold” rating to a “buy” rating and set a $41.00 target price on the stock in a research note on Wednesday, September 20th. BidaskClub raised shares of Smith & Nephew SNATS from a “hold” rating to a “buy” rating in a research report on Tuesday, August 1st. Finally, Canaccord Genuity began coverage on shares of Smith & Nephew SNATS in a research report on Wednesday, October 11th. They set a “buy” rating and a $42.00 price target on the stock. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $42.50.

Shares of Smith & Nephew SNATS, Inc. (SNN) traded down $0.44 during trading hours on Monday, reaching $35.96. 2,076,900 shares of the company’s stock were exchanged, compared to its average volume of 506,005. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.08 and a current ratio of 2.18. Smith & Nephew SNATS, Inc. has a one year low of $26.97 and a one year high of $40.43.

The company also recently announced a semiannual dividend, which was paid on Wednesday, November 1st. Investors of record on Friday, October 6th were paid a dividend of $0.246 per share. The ex-dividend date was Thursday, October 5th. This represents a dividend yield of 1.37%.

About Smith & Nephew SNATS

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Institutional Ownership by Quarter for Smith & Nephew SNATS (NYSE:SNN)

Receive News & Stock Ratings for Smith & Nephew SNATS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS Inc. and related stocks with our FREE daily email newsletter.